NCT06486545 2024-08-26Liposomal Irinotecan Combination Regimen for Second-line Treatment of Advanced Gastric CancerHunan Cancer HospitalPhase NA Not yet recruiting18 enrolled
NCT06078670 2023-10-12PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid TumorsFujian Cancer HospitalPhase 1/2 Not yet recruiting96 enrolled